SURVYR

TECH

Bio-Techne Corporation
$72.69
+$0.09 (0.12%)Oct 28 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-32%-21%-9%+3%+15%Oct 2025Oct 2026Apr 202652w high $72.6952w low $43.20
TECHSPY
Wall St. Highest PT $73.00 (+0.4%) Wall St. Avg PT $70.50 (-3.0%)
$43$51$59$67$75POC $72Hi $73Avg $70
Underwater Drawdown %Max DD -39.3%Current 0.0%
0.0%-39.3%
Relative Strength vs SPY-0.1% vs SPYUnderperforming
+47%0%-47%
1W
+$0.05 (0.07%)
1M
+$0.18 (0.25%)
3M
+$0.74 (1.03%)
6M
+$20.89 (40.34%)
YTD
+$14.13 (24.13%)
1Y
+$9.11 (14.33%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Hold
10 analysts · mean score 2.85
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$72.69
Average target$70.50
−$2.19 (−3.0%) downsideaverage target vs current price
CurrentAverageMedian
Low$50.00
Median$73.00
High$73.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$11.4B
P/E (last 12 months)62.5
P/E (next 12 months, estimated)31.4
52-week range$43.20 – $72.69
Revenue growth (latest quarter vs a year ago)+1.3%
Dividend yield0.44%
Analyst consensusHold (10)
Average analyst price target$70.50 (-3%)

What they do

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy.

Healthcare · Biotechnology
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
46th percentile in sector
C
12-1 return: +16.5%
Percentile within its GICS sector across the S&P 1500.
Growth
15th percentile in sector
D-
Revenue growth (YoY): +1.3%
Percentile within its GICS sector across the S&P 1500.
Value
13th percentile in sector
D-
Forward E/P: 3.2% · EBITDA/EV: 2.9%
Percentile within its GICS sector across the S&P 1500.
Profitability
58th percentile in sector
B-
Profit margin: +15.0% · Return on equity: +9.0%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 134 of 499 · 12-month momentum 30.7%
 Momentum Blend
Not in the current book
 New Highs Growth
ranked 43 of 589 · 12-month momentum 39.2%
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

TECH earningsNext report in 11 days
Next report
Mon Nov 9, 2026Before the open
EPS consensus$0.45
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 12, 2026$0.52est $0.52+0.1%In line with estimates
May 6, 2026$0.53est $0.53−0.8%In line with estimates
Feb 4, 2026$0.46est $0.43+5.8%Above estimates
Nov 5, 2025$0.42est $0.42−0.4%In line with estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-27 18:11:39 ET
24-1025-0225-0525-0825-1126-0226-0526-080.000.56
EstimateActual (beat)Actual (miss)

News & catalysts

More news
Lennox International Moves Up In Market Cap Rank, Passing Bio-Techne
Nasdaq · Oct 21
Insider trades
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:11:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026